Trudhesa (dihydroergotamine mesylate intranasal) / Impel Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Trudhesa (dihydroergotamine mesylate intranasal) / Impel Pharma
ACTRN12617001381370: A Phase I, Comparative Bioavailability Study of Dihydroergotamine Mesylate (DHE) Administered by I123 Precision Olfactory Delivery (PODTM) Device Nasal Spray, DHE for Injection (Intravenous), and Migranal® Nasal Spray in Healthy Male and Female adult Subjects

Completed
1
36
 
Clinical Network Services (CNS) Pty Ltd, Impel NeuroPharma Inc
Migraine headache
 
 
NCT03401346: Bioavailability of DHE Administered by I123 POD Device, IV Injection, and Migranal Nasal Spray in Healthy Adults

Completed
1
36
RoW
INP104, Dihydroergotamine Mesylate (DHE), Migranal Nasal Spray
Impel NeuroPharma Inc.
Migraine Headache
12/17
12/17

Download Options